The answers you need Find answers to frequently asked questions about our programs
You're getting a full-service telehealth experience that includes: A Detailed Medical Intake: Our clinicians review your health history to ensure you're a safe and appropriate candidate for treatment
BPC-157 + TB-500 Blend is supplied for laboratory research use only
As we age and accumulate chronic illness, natural glutathione tends to decline, which is thought to leave cells more vulnerable to oxidative damage
On 23-24 July 2026, the US Food and Drug Administrations Pharmacy Compounding Advisory Committee recommended that six of seven peptides it assessed (BPC-157, KPV, TB-500,MOTS-c, epitalon and semax) be considered for inclusion on the section 503A Bulks List, potentially permitting their use in patient-specific compounded preparations.[2,7] The votes were close and advisory